Glucagon-like peptide-1 receptor agonist-based regimens compared with metformin-based regimens for preventing cardiovascular disease in adults with type 2 diabetes mellitus

Systematic review published in The Cochrane database of systematic reviews (2026) covering Liraglutide.

Systematic review.

The record

• Journal: The Cochrane database of systematic reviews 8: CD016380
• Published: 2026-08-10
• PMID: 42573030 — DOI: 10.1002/14651858.cd016380
• MeSH terms: Venoms, Humans, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Metformin, Pyrazines, Thiazolidinediones, Peptides, Hypoglycemic Agents, Randomized Controlled Trials as Topic, Isoindoles, Glucagon-Like Peptide-1 Receptor, Liraglutide, Exenatide, Glucagon-Like Peptide-1 Receptor Agonists
• Author countries: India, Spain, USA, Venezuela

Peptide profiles: Liraglutide.

All indexed evidence: Liraglutide trials & papers.

Related studies: Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic…, Relationship Between GLP-1-Based Therapies and Periodontal Health: A Systematic Review…, GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and…, Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a….